Professional Documents
Culture Documents
processing methods
100%
Up to
% Total Nucleated Cell
80%
99.46%*
82%
Recovery Rate
60%
63%
40%
20%
0%
Automated Manual Manual
Closed System: Closed System: Open System:
Sepax 2 Triple Bag Tubes
*Conditions apply
The first private cord blood bank in Singapore that offers the
Sepax 2 automated processing technology, this Swiss-made
and U.S. FDA-cleared device can recover as high as 99.46%1 of
Total Nucleated Cells (TNC) from cord blood; up to 57%2 cell count
higher than other processing methods. It is also a functionally
closed processing system which ensures the sterility of the cord
blood by eliminating exposure to air contaminants.
processing technology
Over 1 million cord blood units3 have been processed by the Sepax System in
over 50 countries, this is almost half of the worldwide processing procedures for
cord blood inventory
Trusted by majority of the worlds leading public and private cord blood banks
The Sepax system has been chosen by over 75% of the Netcord organizations
that group the leading public cord blood banks around the world.
References
1. Cordlife umbilical cord blood processing data as at 30 Apr 2013
2. Valeri et al., Transfusion 1996;36:303-8
3. Biosafe, manufacturer of Sepax (figures accurate as of 31 March 2013)